このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Changes in Physical Activity, Sleep and Knee Function After Same-Day Discharge Knee Arthroplasty (ORTOMOVE)

2026年9月18日 更新者:Juuso Hannula、Turku University Hospital

ORTOMOVE: Protocol for a Prospective Cohort Study Comparing Physical Activity, Sleep Quality and Patient-reported Outcomes Following Same- Day Discharge Knee Arthroplasty

The goal of this observational study is to examine changes in physical activity, sleep quality, knee extension and flexion strength, knee range of motion, and patient-reported outcomes before and after same-day discharge knee arthroplasty (SDD-KA). The study will also investigate whether these changes are associated with each other and with patient satisfaction. As a prespecified secondary aim, researchers will compare these outcomes between patients undergoing medial unicompartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA).

The main questions it aims to answer are:

  • How do physical activity, sleep quality, knee extension and flexion strength, knee range of motion, and patient-reported outcomes change following SDD-KA?
  • Are changes in these outcomes associated with each other and with patient satisfaction?
  • Are these outcomes different between patients undergoing medial UKA and TKA?

Participants will:

  • Wear an accelerometer to measure physical activity and sleep before surgery, continuously from surgery to 3 months after surgery, and again for 2 weeks at 12 months after surgery
  • Complete questionnaires about knee function, sleep quality, pain, health-related quality of life, and satisfaction with surgery
  • Have knee muscle strength and active knee range of motion assessed before and 12 months after surgery
  • Attend follow-up assessments during the 12-month postoperative period

調査の概要

詳細な説明

This is a prospective observational cohort study investigating postoperative recovery in patients undergoing same-day discharge knee arthroplasty (SDD-KA) for knee osteoarthritis. The primary aim is to characterize pre- to postoperative changes in physical activity, sleep quality, knee extension and flexion strength, knee range of motion, and patient-reported outcomes, and to investigate associations among these changes and their relationship with patient satisfaction.

As a prespecified secondary aim, the study will compare these outcomes between patients undergoing medial unicompartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA). Patients are not randomized to UKA or TKA; the surgical procedure is determined by the treating clinical team according to established clinical indications. The study therefore represents an observational comparison of two patient cohorts undergoing different surgical procedures.

The study will include 120 patients undergoing primary SDD-KA at Turku University Hospital, Finland. The cohort will consist of 30 patients undergoing medial UKA and 90 undergoing TKA. Participants will be followed prospectively from the preoperative period through 12 months after surgery.

Physical activity and sleep will be assessed objectively using wearable accelerometers. Measurements will be performed during a two-week period before surgery, continuously from the time of surgery through 3 months postoperatively, and during a further two-week measurement period at 12 months postoperatively. Accelerometer data will be analysed at the UKK Institute for Health Promotion Research using validated algorithms. Clinical assessments will include isometric knee extension and flexion strength and active knee range of motion. Patient-reported outcomes will include knee-specific function, sleep quality, pain, health-related quality of life, and satisfaction with surgery. Assessments will be performed at predefined time points during the preoperative and postoperative follow-up period. The study is designed to provide an integrated assessment of recovery by combining objective wearable sensor-derived measures with standardized clinical assessments and patient-reported outcomes.

After completion of the 12-month follow-up, the data will be analysed by the study statistician. Baseline characteristics and outcome measures will be summarized descriptively. The primary analysis will evaluate the change in Oxford Knee Score (OKS) from baseline to 12 months in the whole cohort. As a secondary analysis, the change in OKS will be compared between the UKA and TKA groups.

Changes in outcomes over time will be assessed using linear mixed-effects models, where appropriate. Associations between physical activity variables, knee extension and flexion strength, range of motion and OKS will be assessed using models with a patient-level random effect for OKS, and with physical activity, strength, range of motion, time point and potential confounders as fixed effects. The patient-level random effect allows for handling the situations where some patients may have data missing at some time point, thus reducing the potential impact of dropout on the results. Potential confounders, including age, sex, body mass index, and ASA physical status classification, will be considered in the analyses. Multivariable regression analyses will also be used to examine associations between changes in the outcome measures.

As treatment allocation is based on clinical indication rather than randomisation, the UKA and TKA groups are expected to differ in baseline characteristics. Comparisons between the groups will therefore be adjusted for baseline characteristics, and residual confounding cannot be excluded. No adjustment for multiple comparisons will be made; analyses of secondary outcomes are considered exploratory and will be interpreted accordingly. Results will be presented with 95% confidence intervals. Statistical significance will be set at p<0.05.

Data will be collected prospectively according to a predefined study protocol. Clinical assessments and questionnaires will be performed using standardized procedures, and wearable sensor data will be collected according to the predefined measurement schedule. Data quality will be monitored through review of collected study data and checks for completeness and consistency. Missing or incomplete measurements will be documented and handled according to the prespecified statistical analysis plan.

The study will increase understanding of modifiable factors associated with recovery and satisfaction after KA. The findings may inform patient selection and support the optimisation of postoperative rehabilitation, and may help identify factors influencing recovery and surgical outcomes. Furthermore, the results may provide a foundation for designing interventions aimed at increasing postoperative mobilisation and physical activity, potentially using activity monitors to support optimal recovery, and may guide the design of future comparative studies.

研究の種類

観察的

入学 (推定)

120

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Matias Hemmilä, Ph.D.
  • 電話番号:+358440607840
  • メール:mmhemm@utu.fi

研究連絡先のバックアップ

  • 名前:Juuso Hannula, Ph.D. student
  • 電話番号:+358505017676
  • メール:juaukh@utu.fi

研究場所

      • Tampere、フィンランド
        • 募集
        • The UKK Institute for Health Promotion Research
        • コンタクト:
      • Turku、フィンランド
        • 募集
        • Turku University Hospital
        • コンタクト:
          • Matias Hemmilä, Ph.D.
          • 電話番号:+358440607840
          • メール:mmhemm@utu.fi

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

80年歳未満 (子、大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

The study population consists of patients undergoing same-day discharge primary knee arthroplasty: medial UKA or TKA according to standard clinical practice at Turku University Hospital. The choice of procedure is made on clinical grounds by the treating surgeon and is not influenced by study participation. Operations are performed by experienced arthroplasty surgeons under spinal anaesthesia following the hospital's standardized same-day discharge protocol.

説明

Inclusion Criteria:

- Primary knee osteoarthritis: medial or lateral Kellgren Lawrence grade 3-4 for TKA and antero-medial grade 3-4 for UKA.

Patient criteria for outpatient knee arthroplasty (UKA or TKA):

  • Full overnight support by an adult at home after discharge
  • At most mild, well-controlled, comorbidities (e.g. hypertension, hypothyroidism, epilepsy, asthma)
  • ASA-class 1-2
  • Age <80 years
  • BMI <35 kg/m2

Exclusion Criteria:

  • Post-traumatic osteoarthritis
  • Neurological disorder aVecting walking or muscle strength
  • Inability or unwillingness to use a smartphone or to participate in the study

Exclusion criteria for outpatient surgery:

  • History of cardiac or cerebrovascular events
  • Conditions affecting consciousness (e.g. syncope of cardiac origin)
  • Untreated or central sleep apnoea
  • Heart failure
  • Diabetes mellitus type 1
  • Cognitive impairment or dementia
  • History of substance abuse
  • Chronic strong opioid therapy or severe pain disorder
  • Antithrombotic therapy (e.g. Xarelto, Pradaxa, Plavix or ASA for secondary prevention)
  • History of venous thromboembolism or known coagulopathy

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
Medial unicompartmental knee arthroplasty (UKA)

Patients undergoing primary same-day discharge medial unicompartmental knee arthroplasty (UKA) for knee osteoarthritis. The medial UKA group will include 30 participants. The surgical procedure is determined by the treating clinical team according to established clinical indications and is not assigned by the study.

Primary medial UKA performed as part of routine clinical care for knee osteoarthritis. The procedure is not assigned by the study.

Total Knee Arthroplasty (TKA)

Patients undergoing primary same-day discharge total knee arthroplasty (TKA) for knee osteoarthritis. The TKA group will include 90 participants. The surgical procedure is determined by the treating clinical team according to established clinical indications and is not assigned by the study.

Primary TKA performed as part of routine clinical care for knee osteoarthritis. The procedure is not assigned by the study.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Oxford Knee Score (OKS)
時間枠:The OKS will be completed by participants at baseline before surgery and at 3 and 12 months after surgery. The primary outcome is the change in OKS from baseline to 12 months after surgery.

A 12-item patient-reported questionnaire assessing knee pain and function during daily activities. Each item is scored from 0 to 4, giving a total score ranging from 0 to 48. Higher scores indicate better knee function and less pain.

The OKS will be completed by participants at baseline before surgery and at 3 and 12 months after surgery. The primary outcome is the change in OKS from baseline to 12 months after surgery.

二次結果の測定

結果測定
メジャーの説明
時間枠
Objectively measured physical activity (sensor)
時間枠:Measurements will be performed during a two-week period before surgery, continuously from surgery to 3 months postoperatively, and during a further two-week period at 12 months after surgery.

Physical activity will be assessed objectively using a wearable accelerometer worn by participants during daily life. The accelerometer will continuously record movement during the predefined measurement periods. Physical activity will be characterized using accelerometer-derived measures of activity, including time spent at different levels of physical activity and daily activity patterns.

Measurements will be performed during a two-week period before surgery, continuously from surgery to 3 months postoperatively, and during a further two-week period at 12 months after surgery.
Objectively measured sleep (sensor)
時間枠:Measurements will be performed during a two-week period before surgery, continuously from surgery to 3 months postoperatively, and during a further two-week period at 12 months after surgery.

Sleep will be assessed objectively using a wearable accelerometer worn by participants during daily life. Sleep-related measures will be derived from accelerometer recordings during the predefined measurement periods. Sleep measures will be used to characterize changes in sleep patterns.

Measurements will be performed during a two-week period before surgery, continuously from surgery to 3 months postoperatively, and during a further two-week period at 12 months after surgery.
Isometric knee extension and flexion strength
時間枠:Measurements will be performed before surgery and at 12 months after surgery.

Isometric knee extension and flexion strength will be assessed using a standardized strength measurement procedure. Participants will perform a maximal voluntary isometric knee extension and flexion contraction, and the maximal force produced will be recorded. Higher values indicate greater knee muscle strength.

Measurements will be performed before surgery and at 12 months after surgery.
Knee range of motion
時間枠:Measurements will be performed before surgery and at 12 months after surgery.

Active knee range of motion will be assessed by measuring knee flexion and extension using a standardized clinical measurement procedure. Knee range of motion will be recorded in degrees. Greater knee flexion and less limitation in knee extension indicate better knee mobility.

Measurements will be performed before surgery and at 12 months after surgery.
Jenkins Sleep Scale (JSS)
時間枠:The JSS will be completed at 2 weeks preoperatively and 12 months postoperatively.

The Jenkins Sleep Scale (JSS) is a 4-item patient-reported questionnaire assessing the frequency of common sleep problems during the previous month. Each item is scored from 0 to 5, giving a total score ranging from 0 to 20. Higher scores indicate more frequent sleep problems and poorer sleep quality.

The JSS will be completed at 2 weeks preoperatively and 12 months postoperatively.
Pain -visual analogue scale (VAS)
時間枠:Measurements will be performed before surgery, 3 and 12 months after surgery.

Pain intensity will be assessed using a visual analogue scale. Participants will rate their pain on a continuous scale from 0 to 100 mm, where 0 indicates no pain and 100 indicates the worst pain imaginable. Pain will be assessed both at rest and during movement. Higher scores indicate greater pain intensity.

Measurements will be performed before surgery, 3 and 12 months after surgery.
Health-related quality of life
時間枠:The questionnaire will be completed preoperatively, 3 and 12 months postoperatively.

Health-related quality of life will be assessed using the 15D questionnaire, a standardized patient-reported measure covering 15 dimensions of health, including mobility, physical functioning, pain, sleep, and mental well-being. The 15D produces a single index score ranging from 0 to 1, where 0 represents the worst possible health state and 1 represents the best possible health state. Higher scores indicate better health-related quality of life.

The questionnaire will be completed preoperatively, 3 and 12 months postoperatively.
Patient satisfaction
時間枠:Satisfaction will be assessed at 3 and 12 months postoperatively.

Patient satisfaction with the outcome of knee arthroplasty will be assessed using a 5-point Likert scale. Participants will rate their overall satisfaction with the result of surgery, ranging from very dissatisfied to very satisfied. Higher scores indicate greater satisfaction with the surgical outcome.

Satisfaction will be assessed at 3 and 12 months postoperatively.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

協力者

捜査官

  • スタディチェア:Ville Äärimaa, Title of Docent、Turku University Hospital
  • スタディチェア:Keijo Mäkelä, Professor、Turku University Hospital

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年8月1日

一次修了 (推定)

2029年2月1日

研究の完了 (推定)

2029年2月1日

試験登録日

最初に提出

2026年9月18日

QC基準を満たした最初の提出物

2026年9月18日

最初の投稿 (実際)

2026年9月25日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月25日

QC基準を満たした最後の更新が送信されました

2026年9月18日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

There is currently no plan to make individual participant data (IPD) available to other researchers. The study will collect individual-level clinical, patient-reported, and wearable sensor data, and any sharing of such data would be subject to applicable data protection requirements, ethical considerations, and institutional policies.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する